These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 37309225

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chronic lymphocytic leukemia and secondary hematological malignancies: A nation-wide cancer registry study.
    Lenartova A, Johannesen TB, Tjønnfjord GE.
    Eur J Haematol; 2020 Jun; 104(6):546-553. PubMed ID: 32058605
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW, Weaver AL, Shanafelt TD, Habermann TM, Wriston CC, Cerhan JR, Call TG, Brewer JD.
    Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
    [Abstract] [Full Text] [Related]

  • 5. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD, Shanafelt TD, Call TG, Cerhan JR, Roenigk RK, Weaver AL, Otley CC.
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
    Falchi L, Vitale C, Keating MJ, Lerner S, Wang X, Elhor Gbito KY, Strom S, Wierda WG, Ferrajoli A.
    Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
    [Abstract] [Full Text] [Related]

  • 12. Trends in hematological cancer in the elderly in Denmark, 1980-2012.
    Ocias LF, Larsen TS, Vestergaard H, Friis LS, Abildgaard N, Frederiksen H, Academy of Geriatric Cancer Research (AgeCare).
    Acta Oncol; 2016 Jun; 55 Suppl 1():98-107. PubMed ID: 26783877
    [Abstract] [Full Text] [Related]

  • 13. Risk of hematological malignancy in blood donors: A nationwide cohort study.
    Zhao J, Dahlén T, Brynolf A, Edgren G.
    Transfusion; 2020 Nov; 60(11):2591-2596. PubMed ID: 32818321
    [Abstract] [Full Text] [Related]

  • 14. Estimating the risk of developing secondary hematologic malignancies in patients with T1/T2 prostate cancer undergoing diverse treatment modalities: A large population-based study.
    Mo X, Zhou M, Yan H, Chen X, Wang Y.
    Cancer Med; 2021 Aug; 10(15):5338-5346. PubMed ID: 34189859
    [Abstract] [Full Text] [Related]

  • 15. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM, Schonfeld SJ, Dores GM, Engels EA, Tucker MA, Curtis RE, Morton LM.
    Blood Adv; 2019 Jul 09; 3(13):1961-1969. PubMed ID: 31262739
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland.
    McKenna DB, Stockton D, Brewster DH, Doherty VR.
    Br J Cancer; 2003 Jan 13; 88(1):74-8. PubMed ID: 12556962
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.